Literature DB >> 20672841

Falcipain inhibitors: optimization studies of the 2-pyrimidinecarbonitrile lead series.

Jose M Coterón1, David Catterick, Julia Castro, María J Chaparro, Beatriz Díaz, Esther Fernández, Santiago Ferrer, Francisco J Gamo, Mariola Gordo, Jiri Gut, Laura de las Heras, Jennifer Legac, Maria Marco, Juan Miguel, Vicente Muñoz, Esther Porras, Juan C de la Rosa, Jose R Ruiz, Elena Sandoval, Pilar Ventosa, Philip J Rosenthal, Jose M Fiandor.   

Abstract

Falcipain-2 and falcipain-3 are papain-family cysteine proteases of the malaria parasite Plasmodium falciparum that are responsible for host hemoglobin hydrolysis to provide amino acids for parasite protein synthesis. Different heteroarylnitrile derivatives were studied as potential falcipain inhibitors and therefore potential antiparasitic lead compounds, with the 5-substituted-2-cyanopyrimidine chemical class emerging as the most potent and promising lead series. Through a sequential lead optimization process considering the different positions present in the initial scaffold, nanomolar and subnanomolar inhibitors at falcipains 2 and 3 were identified, with activity against cultured parasites in the micromolar range. Introduction of protonable amines within lead molecules led to marked improvements of up to 1000 times in activity against cultured parasites without noteworthy alterations in other SAR tendencies. Optimized compounds presented enzymatic activities in the picomolar to low nanomolar range and antiparasitic activities in the low nanomolar range.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20672841     DOI: 10.1021/jm100556b

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


  22 in total

1.  Analysis of non-peptidic compounds as potential malarial inhibitors against Plasmodial cysteine proteases via integrated virtual screening workflow.

Authors:  Thommas M Musyoka; Aquillah M Kanzi; Kevin A Lobb; Özlem Tastan Bishop
Journal:  J Biomol Struct Dyn       Date:  2016-01-28

2.  Artemisinin activity against Plasmodium falciparum requires hemoglobin uptake and digestion.

Authors:  Nectarios Klonis; Maria P Crespo-Ortiz; Iveta Bottova; Nurhidanatasha Abu-Bakar; Shannon Kenny; Philip J Rosenthal; Leann Tilley
Journal:  Proc Natl Acad Sci U S A       Date:  2011-06-27       Impact factor: 11.205

3.  Design and evaluation of primaquine-artemisinin hybrids as a multistage antimalarial strategy.

Authors:  Rita Capela; Ghislain G Cabal; Philip J Rosenthal; Jiri Gut; Maria M Mota; Rui Moreira; Francisca Lopes; Miguel Prudêncio
Journal:  Antimicrob Agents Chemother       Date:  2011-08-01       Impact factor: 5.191

4.  Antimalarial Drug Discovery: From Quinine to the Dream of Eradication.

Authors:  Adam R Renslo
Journal:  ACS Med Chem Lett       Date:  2013-12-12       Impact factor: 4.345

5.  Novel anti-plasmodial hits identified by virtual screening of the ZINC database.

Authors:  Grace Mugumbate; Ana S Newton; Philip J Rosenthal; Jiri Gut; Rui Moreira; Kelly Chibale; Rita C Guedes
Journal:  J Comput Aided Mol Des       Date:  2013-10-25       Impact factor: 3.686

6.  Phosphonium lipocations as antiparasitic agents.

Authors:  Timothy E Long; Xiao Lu; Melina Galizzi; Roberto Docampo; Jiri Gut; Philip J Rosenthal
Journal:  Bioorg Med Chem Lett       Date:  2012-02-23       Impact factor: 2.823

7.  Enone- and chalcone-chloroquinoline hybrid analogues: in silico guided design, synthesis, antiplasmodial activity, in vitro metabolism, and mechanistic studies.

Authors:  Eric M Guantai; Kanyile Ncokazi; Timothy J Egan; Jiri Gut; Philip J Rosenthal; Ravi Bhampidipati; Anitha Kopinathan; Peter J Smith; Kelly Chibale
Journal:  J Med Chem       Date:  2011-05-05       Impact factor: 7.446

Review 8.  Recent advances in malaria drug discovery.

Authors:  Marco A Biamonte; Jutta Wanner; Karine G Le Roch
Journal:  Bioorg Med Chem Lett       Date:  2013-03-27       Impact factor: 2.823

9.  1,4-naphthoquinone cations as antiplasmodial agents: hydroxy-, acyloxy-, and alkoxy-substituted analogues.

Authors:  Xiao Lu; Ali Altharawi; Jiri Gut; Philip J Rosenthal; Timothy E Long
Journal:  ACS Med Chem Lett       Date:  2012-10-01       Impact factor: 4.345

10.  Design, synthesis, crystal structure and anti-plasmodial evaluation of tetrahydrobenzo[4,5]thieno[2,3-d]pyrimidine derivatives.

Authors:  Kavita Pal; Md Kausar Raza; Jenny Legac; Md Ataur Rahman; Shoaib Manzoor; Philip J Rosenthal; Nasimul Hoda
Journal:  RSC Med Chem       Date:  2021-05-18
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.